[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-352350-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-352350-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","imp-metabolic-mechanisms-and-impdh-targeting-strategies-in-tumor-metabolic-reprogramming-and-therapy-review","IMP metabolic mechanisms and IMPDH targeting strategies in tumor metabolic reprogramming and therapy - Review","","Metabolic reprogramming drives malignant tumor behavior by reshaping cell-autonomous metabolic pathways under oncogenic signaling and transcriptional control. Monitoring these rewired networks supports cancer diagnosis, detection, and therapy, while fixed core targets remain promising drug strategies. Inosine monophosphate (IMP) is highlighted as an essential purine synthesis intermediate with strong therapeutic potential, yet the regulatory circuitry governing IMP metabolism in tumor cells requires clarification. This review integrates new IMP metabolism insights, covering precursor substrate supply, dynamic enzyme control, purinosomes, key signaling routes, and downstream links between IMPDH and the immune microenvironment.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/imp-metabolic-mechanisms-and-impdh-targeting-strategies-in-tumor-metabolic-reprogramming-and-therapy-review/352350/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/imp-metabolic-mechanisms-and-impdh-targeting-strategies-in-tumor-metabolic-reprogramming-and-therapy-review/352350.png","ImageObject",300,407,{"name":42,"@type":43},"Noah","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-31","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",15,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Why is metabolic reprogramming central to malignant tumors?","Question",{"text":63,"@type":64},"Metabolic reprogramming is a hallmark of malignant tumors because metabolic pathways are regulated by oncogenic signaling and transcriptional networks, and their dysregulation supports cancer development and progression.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What makes IMP a promising target in tumor therapy?",{"text":68,"@type":64},"IMP is an essential intermediate in purine nucleotide synthesis and shows significant target potential, because tumor cells increase their demand for purines to sustain rapid proliferation.",{"name":70,"@type":61,"acceptedAnswer":71},"Which mechanisms does the review cover to explain IMP metabolism control?",{"text":72,"@type":64},"The review integrates precursor supply (glucose, serine/one-carbon, glutamine and mitochondrial metabolism), dynamic regulation of key enzymes (including IMPDH), purinosomes, and signaling pathways such as RAS-ERK, PI3K/AKT-mTORC1, and Hippo-YAP.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},352350,1790210573,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":128,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":26,"preview_urls":146},8796095462418,"https://ap-avatar.wpscdn.com/avatar/80000253c1241d02b47?x-image-process=image/resize,m_fixed,w_180,h_180&k=1778826106357471780","INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE 57: 81, 2026  \nIMP metabolic mechanisms and IMPDH targeting strategies in tumor metabolic reprogramming and therapy (Review)  \nHAO ZHU 1,2* , HAO WANG 1,2* , XIALI3* , WEISONG ZHANG 1,2 , YIHAO WANG 1,2 , QINGZE TAN 1,2 , DONGXU YING 1,2 , ZHAN SHI 1 and JIANXIANG SONG 1  \n1Department of Thoracic Surgery, Affiliated Hospital 6 of Nantong University, Yancheng Third People's Hospital, Yancheng, 2 3  \nJiangsu 224000, P.R. China; Medical School of Nantong University, Nantong, Jiangsu 226001, P.R. China; Department of General Medicine, Affiliated Hospital 6 of Nantong University, Yancheng Third People's Hospital, Yancheng, Jiangsu 224000, P.R. China  \nReceived November 14, 2025; Accepted January 16, 2026  \nDOI: 10.3892/ijmm.2026.5752  \nAbstract. Metabolic reprogramming is a hallmark feature of malignant tumors. These metabolic pathways are regulated in a cell‑autonomous manner by oncogenic signaling and transcriptional networks, and tracking their metabolic repro‑ gramming is frequently used in the diagnosis, detection and treatment of cancer. There are currently promising therapeutic prospects for a variety of types targeting fixed core metabolic pathways in tumor metabolic reprogramming. Among these, inosine monophosphate (IMP) is an essential intermediate in purine nucleotide synthesis that demonstrates significant target potential. Nevertheless, further research is needed to elucidate the regulatory networks that control IMP metabolism in tumor cells. This review combines the latest insights into IMP metabolism into an interesting conceptual framework. This includes the supply of IMP precursor substrates (reprogram‑ ming of glucose metabolism, serine/one‑carbon metabolism, glutamine and mitochondrial metabolism), the dynamic regu‑ lation of important enzymes [phosphoribosyl pyrophosphate synthetase, phosphoribosyl pyrophosphate amidotransferase, IMP dehydrogenase (IMPDH)], purinosomes and signaling pathways (RAS‑ERK, PI3K/AKT‑mTORC1 and Hippo‑YAP) that ultimately regulate IMP synthesis in tumor cells. Additionally, it focused on downstream associations between IMPDH and the immune microenvironment, offering a fresh perspective for current research on tumor therapy targeting IMP metabolism.  \nCorrespondence to: Professor Jianxiang Song or Professor Zhan Shi, Department of Thoracic Surgery, Affiliated Hospital 6 of Nantong University, Yancheng Third People's Hospital, 2 Xindu West Road, Yandu, Yancheng, Jiangsu 224000, P.R. China  \nE‑mail: [jxsongycsy@163.com](jxsongycsy@163.com)  \nE‑mail: [shizhan5300864@ntu.edu.cn](shizhan5300864@ntu.edu.cn)  \n*Contributed equally  \nKey words: IMPDH, metabolic reprogramming, IMP metabolism, cancer, purinosome, signaling pathways  \nContents  \n1. Introduction  \n2. Precursor supply: The metabolic network driving de novo synthesis of IMP flux  \n3. Dynamic regulation of xanthine deoxynucleotidyl trans‑ ferase in cancer  \n4. Cellular signaling pathways regulate the production of de novo IMP  \n5. IMPDH targeting strategy  \n6. Conclusion and outlook  \n1. Introduction  \nInosine monophosphate (IMP), as a crucial intermediate in the metabolism of purine nucleotides, is essential for both de novo synthesis and salvage synthesis pathways (1). The body effec‑ tively recovers ~90% of free bases in the salvage pathway through hypoxanthine‑guanine phosphoribosyltransferase, using resources to synthesize the necessary IMP and guanine monophosphate. The regular demands of the body are mainly satisfied by this mechanism (2) . However, salvage synthesis is unable to keep up with the growing need for purines due to the rapid proliferation of tumor cells . The primary mechanism at this stage is de novo synthesis (3,4), which uses 5'‑ribose‑5'‑phosphate as its absolute starting substrate (a common precursor for all purine nucleotide synthesis, usually not listed separately) and catalyzes reactions through trifunctional enzymes [trifunctional glycinamide nucleoside transcarbo","cbCaijGkzuY6UJaU","https://ap.wps.com/l/cbCaijGkzuY6UJaU","pdf",4130399,"English","# Introduction\n## Precursor supply: the metabolic network driving de novo synthesis of IMP flux\n## Dynamic regulation of xanthine deoxynucleotidyl transferase in cancer\n## Cellular signaling pathways regulate production of de novo IMP\n## IMPDH targeting strategy\n## Conclusion and outlook","[{\"question\":\"Why is metabolic reprogramming central to malignant tumors?\",\"answer\":\"Metabolic reprogramming is a hallmark of malignant tumors because metabolic pathways are regulated by oncogenic signaling and transcriptional networks, and their dysregulation supports cancer development and progression.\"},{\"question\":\"What makes IMP a promising target in tumor therapy?\",\"answer\":\"IMP is an essential intermediate in purine nucleotide synthesis and shows significant target potential, because tumor cells increase their demand for purines to sustain rapid proliferation.\"},{\"question\":\"Which mechanisms does the review cover to explain IMP metabolism control?\",\"answer\":\"The review integrates precursor supply (glucose, serine/one-carbon, glutamine and mitochondrial metabolism), dynamic regulation of key enzymes (including IMPDH), purinosomes, and signaling pathways such as RAS-ERK, PI3K/AKT-mTORC1, and Hippo-YAP.\"}]","IMP metabolic mechanisms and IMPDH targeting strategies in tumor metabolic reprogramming and therapy - Review | PDF",1790099125,48,[147,151],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-08/d6ff032edc4e7c35ba37951142ec678c.webp",983,1357,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-08/17b1d8f44b7c5b63770af8ae8afa7b70.webp",982,1356]